ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Kimia Biosciences' board meeting outcome includes director appointments, approval of the 33rd AGM notice, and increased borrowing/investment limits. The board also adopted the annual report.
Kimia Biosciences appointed a new Cost Auditor, Internal Auditor, and Secretarial Auditor, while discontinuing the previous Secretarial Auditor following its recent Board Meeting.
Kimia Biosciences Ltd announced several board changes following its April 18, 2026 meeting. Key updates include the cessation of Independent Director Ms. Richa Gupta and the appointment of Mr. Amulya Kumar Nayak as a Non-Executive Director. Additionally, the company modified the terms for Managing Director Mr. Sameer Goel to include retirement by rotation.